We are live on ! Find out more
ELV icon

Elevance Health

1,510 hedge funds and large institutions have $63.3B invested in Elevance Health in 2025 Q3 according to their latest regulatory filings, with 165 funds opening new positions, 531 increasing their positions, 608 reducing their positions, and 223 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more call options, than puts

Call options by funds: $953M | Put options by funds: $837M

0% more funds holding in top 10

Funds holding in top 10: 3232 (0)

3.76% less ownership

Funds ownership: 90.78%87.02% (-3.8%)

5% less funds holding

Funds holding: 1,5891,510 (-79)

13% less repeat investments, than reductions

Existing positions increased: 531 | Existing positions reduced: 608

21% less capital invested

Capital invested by funds: $79.7B → $63.3B (-$16.4B)

26% less first-time investments, than exits

New positions opened: 165 | Existing positions closed: 223

Holders
1,510
Holders Change
-79
Holders Change %
-4.97%
% of All Funds
19.82%
Holding in Top 10
32
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.42%
New
165
Increased
531
Reduced
608
Closed
223
Calls
$953M
Puts
$837M
Net Calls
+$117M
Net Calls Change
-$94.6M
Name Holding Trade Value Shares
Change
Change in
Stake
Dimensional Fund Advisors
26
Dimensional Fund Advisors
Texas
$539M -$2.72M -8,756 -0.5%
Eagle Capital Management (New York)
27
Eagle Capital Management (New York)
New York
$508M -$1.01M -3,259 -0.2%
Arrowstreet Capital
28
Arrowstreet Capital
Massachusetts
$488M +$177M +569,008 +60%
RCG
29
Ruane, Cunniff & Goldfarb
New York
$468M +$110M +352,628 +32%
Goldman Sachs
30
Goldman Sachs
New York
$456M +$5.65M +18,163 +1%
Fidelity Investments
31
Fidelity Investments
Massachusetts
$444M +$28.7M +92,235 +7%
Bank of New York Mellon
32
Bank of New York Mellon
New York
$434M +$13.3M +42,821 +3%
BG
33
Baupost Group
Massachusetts
$426M +$219M +703,000 +114%
OAG
34
Orbis Allan Gray
Bermuda
$423M -$481M -1,547,732 -54%
Amundi
35
Amundi
France
$393M -$87.5M -281,381 -20%
JP Morgan Chase
36
JP Morgan Chase
New York
$390M -$82.5M -265,415 -18%
Newport Trust Company
37
Newport Trust Company
District of Columbia
$331M -$6.85M -22,027 -2%
MGP
38
M&G plc
United Kingdom
$328M +$26.4M +84,820 +9%
Franklin Resources
39
Franklin Resources
California
$321M -$80.1M -257,603 -19%
Sumitomo Mitsui Trust Group
40
Sumitomo Mitsui Trust Group
Japan
$305M +$2.5M +8,023 +0.9%
UBS Group
41
UBS Group
Switzerland
$300M +$26M +83,508 +10%
AllianceBernstein
42
AllianceBernstein
Tennessee
$295M -$150M -482,748 -35%
VAM
43
Veritas Asset Management
United Kingdom
$292M -$3.25M -10,458 -1%
Deutsche Bank
44
Deutsche Bank
Germany
$272M +$10.1M +32,490 +4%
AQR Capital Management
45
AQR Capital Management
Connecticut
$259M +$170M +547,950 +216%
D.E. Shaw & Co
46
D.E. Shaw & Co
New York
$250M +$39.2M +125,879 +19%
1832 Asset Management
47
1832 Asset Management
Ontario, Canada
$243M -$10.6M -34,100 -4%
Ameriprise
48
Ameriprise
Minnesota
$234M -$358M -1,150,939 -61%
BGC
49
Beutel, Goodman & Co
Ontario, Canada
$232M -$11.1M -35,831 -5%
First Trust Advisors
50
First Trust Advisors
Illinois
$225M -$50M -160,632 -19%

ELV Hedge Fund Activity: Q3 2025 in Review

1,510 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Elevance Health (ELV) for Q3 2025, worth a combined $63.3B — down 21% from $79.7B a quarter earlier.

Sellers outnumbered buyers: 223 funds closed out of ELV and 165 opened new positions — a net loss of 58 holders — while 608 trimmed existing stakes and 531 added.

The largest buyer was Harris Associates, adding an estimated $281M. The largest seller was Capital International Investors, cutting an estimated $1.1B.

  • 1,510 institutional investors held Elevance Health (ELV) as of Q3 2025, down from 1,589 in Q2 2025.
  • Funds reported $63.3B of Elevance Health stock for Q3 2025, down 21% quarter-over-quarter.
  • 165 funds opened new Elevance Health positions in Q3 2025 and 223 closed out, a net change of -58 holders.
  • The largest Elevance Health buyer in Q3 2025 was Harris Associates, an estimated $281M added.
  • The largest Elevance Health seller in Q3 2025 was Capital International Investors, an estimated $1.1B sold.

Based on aggregated 13F filings for Q3 2025.